Cargando…
INSM1 Expression in Breast Neoplasms with Neuroedocrine Features
According to the 2019 WHO classification of breast tumors, neuroendocrine neoplasms (NENs) are classified into well-differentiated NE tumors (NET) and poorly differentiated NE carcinomas (NEC), while other breast cancers (BCs) of special and no special type with neuroendocrine (NE) features are not...
Autores principales: | Metovic, Jasna, Castellano, Isabella, Marinelli, Eleonora, Osella-Abate, Simona, Sapino, Anna, Cassoni, Paola, Papotti, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608773/ https://www.ncbi.nlm.nih.gov/pubmed/34008122 http://dx.doi.org/10.1007/s12022-021-09682-1 |
Ejemplares similares
-
Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome
por: Metovic, Jasna, et al.
Publicado: (2022) -
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling
por: Vissio, Elena, et al.
Publicado: (2019) -
Overexpression of INSM1, NOTCH1, NEUROD1, and YAP1 genes is associated with adverse clinical outcome in pediatric neuroblastoma
por: Metovic, Jasna, et al.
Publicado: (2022) -
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up
por: Bustreo, Sara, et al.
Publicado: (2016) -
Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis
por: Metovic, Jasna, et al.
Publicado: (2021)